NCT01395550已完成不适用
Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 88
研究概览
简要总结
AstraZeneca was interested in knowing how Cardiologists and Physicians treat patients who have suffered a cardiovascular event.
研究设计
- 研究类型
- Observational
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All patients who has experienced cardiovascular events
排除标准
- •Patients with no cardiovascular events.
研究者
相似试验
已完成
3 期
UMPIRE - Use of a Multidrug Pill In Reducing Cardiovascular EventsCardiovascular DiseasesNCT01057537Imperial College London2,004
已完成
不适用
GlObal Secondary Prevention strategiEs to Limit Event Recurrence After Myocardial Infarction. GOSPEL StudyMyocardial InfarctionNCT00421876Heart Care Foundation3,200
已完成
不适用
Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Chronic Plaque-Type PsoriasisPsoriasisNCT00098189Novartis
已完成
不适用
Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic DermatitisAtopic DermatitisNCT00098150Novartis66
已完成
3 期
Secondary Prevention of Cardiovascular Disease in the Elderly TrialMyocardial InfarctionCardiovascular DiseaseNCT02596126Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III2,499